Linvoseltamab Versus Real-world International Myeloma Working Group Standard-of-care in Triple-class Exposed Relapsed/Refractory Multiple Myeloma Banner
Back
A woman in a white lab coat focused on her work at a computer in a laboratory setting.
Effectiveness of Linvoseltamab Versus Real-world Standard-of-care in Triple-class-exposed Relapsed/Refractory Multiple Myeloma in the United States

Shaji Kumar, Katja C. Weisel, Paul Spin, Nicolle Bonar, Muhaimen Siddiqui, Mostafa Shokoohi, Di Wang, Kevin Hou, Michael E. D. West, Christian Hampp, Jeannette Green, James Harnett, Olivier Humblet, Alexander Breskin, Wenzhen Ge, Jessica J. Jalbert, Rachel E. Sobel, Glenn S. Kroog, Karen Rodriguez Lorenc, Qiufei Ma & Sundar Jagannath

Disease: Cancer
Publication: Blood Cancer Journal
Abstract 1 Apr, 2026
A female scientist in a lab coat typing on a laptop, indicating her involvement in scientific work or experimentation.
Linvoseltamab Versus Real-world International Myeloma Working Group Standard-of-care in Triple-class Exposed Relapsed/Refractory Multiple Myeloma

Shaji Kumar, Sundar Jagannath, Katja C. Weisel, Laura Rosiñol, Xavier Leleu, Meletios-Athanasios Dimopoulos, Efstathios Kastritis, David S. Siegel, Jorge Monge, Juan Du, Javier de la Rubia, Pedro Asensi Cantó, Jae Hoon Lee, María-Victoria Mateos, Borja Puertas, Alessandro Gozzetti, Dominik Dytfeld, Enrique M. Ocio, Joan Blade, Shuji Ozaki, Meral Beksac, Fernando Escalante, Madhu Nagaraj, Rafla Hassan, …Brian G. M. Durie

Disease: Cancer
Publication: Blood Cancer Journal
Abstract 25 Mar, 2026
Health System
Life Sciences
Offerings

© 2026 Guardian Research Network- All Rights Reserved| Legal